Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 108,738 | 120,495 | 125,138 | 102,745 | 89,819 |
| Marketable Securities | 229,446 | 251,657 | 296,545 | 239,481 | 232,944 |
| Receivables | 39,072 | 59,786 | 69,629 | 64,567 | 61,819 |
| Inventories | 12,890 | 12,868 | 12,349 | 12,276 | 14,368 |
| TOTAL | $426,033 | $485,464 | $541,130 | $443,112 | $438,503 |
| Non-Current Assets | |||||
| PPE Net | 3,171 | 1,890 | 2,094 | 2,348 | 2,543 |
| Investments And Advances | 177,261 | 160,270 | 102,557 | 172,775 | 248,041 |
| Other Non-Current Assets | 208,416 | 189,027 | 177,826 | 183,487 | 157,368 |
| TOTAL | $388,848 | $351,187 | $282,477 | $358,610 | $407,952 |
| Total Assets | $814,881 | $836,651 | $823,607 | $801,722 | $846,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33,306 | 40,444 | 34,446 | 23,525 | 27,947 |
| Accrued Expenses | 34,091 | 33,954 | 28,322 | 29,049 | 25,260 |
| TOTAL | $149,185 | $166,085 | $172,265 | $144,664 | $143,066 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,377 | 7,585 | 0 | 5,588 | 5,851 |
| TOTAL | $27,709 | $22,761 | $19,440 | $21,265 | $20,104 |
| Total Liabilities | $176,894 | $188,846 | $191,705 | $165,929 | $163,170 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,352 | 106,374 | 105,188 | 105,372 | 106,045 |
| Common Shares | 141 | 140 | 139 | 138 | 137 |
| Retained earnings | 611,626 | 643,387 | 619,099 | 599,431 | 564,282 |
| Other shareholders' equity | 1,230 | 2,678 | 2,051 | 2,360 | 1,000 |
| TOTAL | $637,987 | $647,805 | $631,902 | $635,793 | $683,285 |
| Total Liabilities And Equity | $814,881 | $836,651 | $823,607 | $801,722 | $846,455 |